229 related articles for article (PubMed ID: 24034558)
1. Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity.
Ou JL; Mizushina Y; Wang SY; Chuang DY; Nadar M; Hsu WL
FEBS J; 2013 Nov; 280(22):5829-40. PubMed ID: 24034558
[TBL] [Abstract][Full Text] [Related]
2. Synergic effect of curcumin and its structural analogue (Monoacetylcurcumin) on anti-influenza virus infection.
Richart SM; Li YL; Mizushina Y; Chang YY; Chung TY; Chen GH; Tzen JT; Shia KS; Hsu WL
J Food Drug Anal; 2018 Jul; 26(3):1015-1023. PubMed ID: 29976394
[TBL] [Abstract][Full Text] [Related]
3. 3-O-galloylated procyanidins from Rumex acetosa L. inhibit the attachment of influenza A virus.
Derksen A; Hensel A; Hafezi W; Herrmann F; Schmidt TJ; Ehrhardt C; Ludwig S; Kühn J
PLoS One; 2014; 9(10):e110089. PubMed ID: 25303676
[TBL] [Abstract][Full Text] [Related]
4. Aurantiamide acetate from baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-κB signaling pathway in Influenza A virus-infected cells.
Zhou B; Yang Z; Feng Q; Liang X; Li J; Zanin M; Jiang Z; Zhong N
J Ethnopharmacol; 2017 Mar; 199():60-67. PubMed ID: 28119097
[TBL] [Abstract][Full Text] [Related]
5. Ching-fang-pai-tu-san inhibits the release of influenza virus.
Hsieh CF; Yen HR; Liu CH; Lin S; Horng JT
J Ethnopharmacol; 2012 Dec; 144(3):533-44. PubMed ID: 23041224
[TBL] [Abstract][Full Text] [Related]
6. 3D-quantitative structure-activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase.
Lai Y; Yan Y; Liao S; Li Y; Ye Y; Liu N; Zhao F; Xu P
Arch Pharm Res; 2020 May; 43(5):489-502. PubMed ID: 32248350
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory influence of the hexapeptidic sequence SLIGRL on influenza A virus infection in mice.
Betts RJ; Mann TS; Henry PJ
J Pharmacol Exp Ther; 2012 Dec; 343(3):725-35. PubMed ID: 22988062
[TBL] [Abstract][Full Text] [Related]
8. Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.
Chen X; Si L; Liu D; Proksch P; Zhang L; Zhou D; Lin W
Eur J Med Chem; 2015 Mar; 93():182-95. PubMed ID: 25681711
[TBL] [Abstract][Full Text] [Related]
9. Potent influenza A virus entry inhibitors targeting a conserved region of hemagglutinin.
Lin D; Luo Y; Yang G; Li F; Xie X; Chen D; He L; Wang J; Ye C; Lu S; Lv L; Liu S; He J
Biochem Pharmacol; 2017 Nov; 144():35-51. PubMed ID: 28774731
[TBL] [Abstract][Full Text] [Related]
10. Anomeric selectivity and influenza A virus inhibition study on methoxylated analogues of Pentagalloylglucose.
Qurat-ul-ain S; Wang W; Yang M; Du N; Wan S; Zhang L; Jiang T
Carbohydr Res; 2015 Jan; 402():152-7. PubMed ID: 25498015
[TBL] [Abstract][Full Text] [Related]
11. Biological Evaluation of Uridine Derivatives of 2-Deoxy Sugars as Potential Antiviral Compounds against Influenza A Virus.
Krol E; Wandzik I; Krejmer-Rabalska M; Szewczyk B
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28777309
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Anti-Influenza A Virus Activity of 6'-amino-6'-deoxy-glucoglycerolipids Analogs.
Ren L; Zhang J; Ma H; Sun L; Zhang X; Yu G; Guan H; Wang W; Li C
Mar Drugs; 2016 Jun; 14(6):. PubMed ID: 27322292
[TBL] [Abstract][Full Text] [Related]
13. Structure-based discovery of anti-influenza virus A compounds among medicines.
Fukuoka M; Minakuchi M; Kawaguchi A; Nagata K; Kamatari YO; Kuwata K
Biochim Biophys Acta; 2012 Feb; 1820(2):90-5. PubMed ID: 22108550
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiviral evaluation of 6'-acylamido-6'-deoxy-α-D-mannoglycerolipids.
Zhang J; Sun Y; Wang W; Zhang X; Li C; Guan H
Carbohydr Res; 2013 Nov; 381():74-82. PubMed ID: 24076433
[TBL] [Abstract][Full Text] [Related]
15. CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry.
Liu S; Li R; Zhang R; Chan CC; Xi B; Zhu Z; Yang J; Poon VK; Zhou J; Chen M; Münch J; Kirchhoff F; Pleschka S; Haarmann T; Dietrich U; Pan C; Du L; Jiang S; Zheng B
Eur J Pharmacol; 2011 Jun; 660(2-3):460-7. PubMed ID: 21536025
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
Wang H; Xu R; Shi Y; Si L; Jiao P; Fan Z; Han X; Wu X; Zhou X; Yu F; Zhang Y; Zhang L; Zhang L; Zhou D; Xiao S
Eur J Med Chem; 2016 Mar; 110():376-88. PubMed ID: 26866456
[TBL] [Abstract][Full Text] [Related]
17. Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains.
Yamada H; Moriishi E; Haredy AM; Takenaka N; Mori Y; Yamanishi K; Okamoto S
Antiviral Res; 2012 Dec; 96(3):344-52. PubMed ID: 23022352
[TBL] [Abstract][Full Text] [Related]
18. Heptapeptide ligands against receptor-binding sites of influenza hemagglutinin toward anti-influenza therapy.
Matsubara T; Onishi A; Yamaguchi D; Sato T
Bioorg Med Chem; 2016 Mar; 24(5):1106-14. PubMed ID: 26833245
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Structure Activity Relationship and Anti-influenza A Virus Evaluation of Oleanolic Acid-Linear Amino Derivatives.
Li W; Yang F; Meng L; Sun J; Su Y; Shao L; Zhou D; Yu F
Chem Pharm Bull (Tokyo); 2019 Nov; 67(11):1201-1207. PubMed ID: 31434835
[TBL] [Abstract][Full Text] [Related]
20. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
Manju S; Sreenivasan K
Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
